Acute Retinal Necrosis: A Multicenter Study on Factors Associated with Visual Outcomes and Retinal Detachment.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY Ocular Immunology and Inflammation Pub Date : 2025-02-14 DOI:10.1080/09273948.2025.2464717
Panuwat Soitong, Yaninsiri Ngathaweesuk, Noppakhun Panyayingyong, Atchara Amphornphruet, Variya Nganthavee, Boonsub Sakboonyarat, Narumon Keorochana
{"title":"Acute Retinal Necrosis: A Multicenter Study on Factors Associated with Visual Outcomes and Retinal Detachment.","authors":"Panuwat Soitong, Yaninsiri Ngathaweesuk, Noppakhun Panyayingyong, Atchara Amphornphruet, Variya Nganthavee, Boonsub Sakboonyarat, Narumon Keorochana","doi":"10.1080/09273948.2025.2464717","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This multicenter study aimed to evaluate visual outcomes and analyze the specific viral pathogens and other factors associated with severe visual impairment (SVI), and retinal detachment (RD) in patients with acute retinal necrosis (ARN).</p><p><strong>Methods: </strong>A retrospective multicenter cohort study included ARN patients who underwent aqueous or vitreous PCR testing. Multivariable mixed-effects Poisson regression was used to identify factors associated with viral pathogens and SVI. A mixed-effects parametric survival-time model was applied to evaluate RD risk factors.</p><p><strong>Results: </strong>A total of 56 patients (65 eyes) diagnosed with ARN were included. 31 patients (47.7%) had a final visual acuity of 20/200 or worse. SVI was associated with zone 1 involvement (aRR 4.2), immunocompromised status (aRR 2.8), and RD (aRR 4.8). RD occurred in 23 patients (35.4%) after an average of 4.26 months from the onset of ARN. The incidence rate of RD was 1.4 per 1,000 eye-days (95% CI: 0.9-2.1. It increased in VZV-ARN cases by 4.02 times (log-rank <i>p</i> = 0.008), patients with retinitis affecting 2-3 quadrants, and in immunocompetent status.</p><p><strong>Conclusion: </strong>Zone 1 involvement, immunocompromised status, and RD were key risk factors for SVI in ARN. RD occurred in approximately one-third of cases. Early and aggressive intervention is essential in VZV-ARN cases, particularly in cases where retinitis involves 2-3 quadrants of the retina and in immunocompetent individuals, to mitigate the risk of RD.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"1-8"},"PeriodicalIF":2.6000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2025.2464717","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This multicenter study aimed to evaluate visual outcomes and analyze the specific viral pathogens and other factors associated with severe visual impairment (SVI), and retinal detachment (RD) in patients with acute retinal necrosis (ARN).

Methods: A retrospective multicenter cohort study included ARN patients who underwent aqueous or vitreous PCR testing. Multivariable mixed-effects Poisson regression was used to identify factors associated with viral pathogens and SVI. A mixed-effects parametric survival-time model was applied to evaluate RD risk factors.

Results: A total of 56 patients (65 eyes) diagnosed with ARN were included. 31 patients (47.7%) had a final visual acuity of 20/200 or worse. SVI was associated with zone 1 involvement (aRR 4.2), immunocompromised status (aRR 2.8), and RD (aRR 4.8). RD occurred in 23 patients (35.4%) after an average of 4.26 months from the onset of ARN. The incidence rate of RD was 1.4 per 1,000 eye-days (95% CI: 0.9-2.1. It increased in VZV-ARN cases by 4.02 times (log-rank p = 0.008), patients with retinitis affecting 2-3 quadrants, and in immunocompetent status.

Conclusion: Zone 1 involvement, immunocompromised status, and RD were key risk factors for SVI in ARN. RD occurred in approximately one-third of cases. Early and aggressive intervention is essential in VZV-ARN cases, particularly in cases where retinitis involves 2-3 quadrants of the retina and in immunocompetent individuals, to mitigate the risk of RD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
期刊最新文献
Ocular Manifestations of Psoriasis: A Systematic Review. Acute Retinal Necrosis: A Multicenter Study on Factors Associated with Visual Outcomes and Retinal Detachment. Cancer Associated Retinopathy Related to Gastrointestinal Stromal Tumor of Stomach: Case Report. Treatment Outcomes in Patients with Acute Syphilitic Posterior Placoid Chorioretinitis. Clinical Features, Complications, and Treatment Outcomes of Pediatric Pars Planitis Cases in a Tertiary Referral Center.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1